Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Journal for Immunotherapy of Cancer
|
January 31, 2019
17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
Cristina Bagacean, Adrian Tempescul, David Ternant, et al.
Oncotarget
|
September 1, 2018
Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
Anne Bordron, Cristina Bagacean, Audrey Mohr, et al.
Oncoimmunology
|
February 7, 2019
The regulatory capacity of B cells directs the aggressiveness of CLL
Audrey Mohr, Marie Cumin, Cristina Bagacean, et al.
Oncotarget
|
October 15, 2017
Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia
Cristina Bagacean, Adrian Tempescul, Christelle Le Dantec, et al.
Haematologica
|
December 17, 2017
Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)
Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, et al.
Journal for Immunotherapy of Cancer
|
April 25, 2019
STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia
Marjolaine Debant, Miguel Burgos, Patrice Hemon, et al.
Annals of Hematology
|
July 16, 2025
Consequences and impacts of PEG-IFNα2a shortage: first lessons from a MPN French center
Laura Cailly, Wayne-Corentin Lambert, Jean-Richard Eveillard, et al.
Leukemia & Lymphoma
|
March 9, 2017
Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study
Driss Chaoui, Sylvain Choquet, Laurence Sanhes, et al.
Journal of Leukocyte Biology
|
July 21, 2021
Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia
Cristina Bagacean, Cristina Adela Iuga, Anne Bordron, et al.
British Journal of Haematology
|
April 21, 2022
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)
Guillaume Manson, Charles Herbaux, Jean-Marc Schiano, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Journal for Immunotherapy of Cancer
|
January 31, 2019
17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
Cristina Bagacean, Adrian Tempescul, David Ternant, et al.
Oncotarget
|
September 1, 2018
Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
Anne Bordron, Cristina Bagacean, Audrey Mohr, et al.
Oncoimmunology
|
February 7, 2019
The regulatory capacity of B cells directs the aggressiveness of CLL
Audrey Mohr, Marie Cumin, Cristina Bagacean, et al.
Oncotarget
|
October 15, 2017
Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia
Cristina Bagacean, Adrian Tempescul, Christelle Le Dantec, et al.
Haematologica
|
December 17, 2017
Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)
Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, et al.
Journal for Immunotherapy of Cancer
|
April 25, 2019
STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia
Marjolaine Debant, Miguel Burgos, Patrice Hemon, et al.
Annals of Hematology
|
July 16, 2025
Consequences and impacts of PEG-IFNα2a shortage: first lessons from a MPN French center
Laura Cailly, Wayne-Corentin Lambert, Jean-Richard Eveillard, et al.
Leukemia & Lymphoma
|
March 9, 2017
Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study
Driss Chaoui, Sylvain Choquet, Laurence Sanhes, et al.
Journal of Leukocyte Biology
|
July 21, 2021
Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia
Cristina Bagacean, Cristina Adela Iuga, Anne Bordron, et al.
British Journal of Haematology
|
April 21, 2022
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)
Guillaume Manson, Charles Herbaux, Jean-Marc Schiano, et al.
Page
of 7